济南市看男科好的医院(济南怎样男人射精快) (今日更新中)

The Trump administration says it's ramping up the distribution of rapid coronavirus tests across the US.According to the Department of Health and Human Services, states are on track to receive close to 37 million BinaxNOW antigen tests by the end of the week.The department says the goal is to protect seniors and help states continue to re-open.Officials say they're part of the 150 million BinaxNOW tests that the federal government already planned to deploy nationwide.Abbott says the way it works is that lays the card flat on a countertop, an extraction reagent is added to the card, then the patient gets swabbed from the nose, and then the technician will insert the swab into the test card and fold it over.Abbott Laboratories - which developed the test - says it delivers results in 15 minutes.The HHS points out that more testing does not replace public health guidelines, including wearing masks and washing hands. 933

The wine advent calendar is making its way back to Costco this year.According to FlyingBlue, the company behind the wine advent calendars, this year's calendar will be on most Costco shelves by the first week of October.Each box would contain 24 half-bottles of wine, FlyingBlue stated on its website.According to CostcoWineBlog, there will be two options available this year.USA Today reports the calendars will cost .The product is only available in stores and will not be available for online purchase. 516

The US Department of Education has opened an investigation into the Ohio State University's handling of former students' allegations of sexual misconduct by a school doctor, according to the university.The federal investigation will be conducted by the department's Office for Civil Rights (OCR), which oversees Title IX complaints, the school said in a statement Thursday.The inquiry, led by the OCR's regional office in Cleveland, Ohio, "will examine whether the university is responding promptly and equitably to complaints and reports by former students," the statement said, "including allegations that employees knew or should have known about the sexual misconduct and allowed the abuse to continue."The scandal surrounding the alleged actions of the late Dr. Richard Strauss has grown since the university first announced in April its own investigation, headed by the law firm Perkins Coie, to look into claims made by male former athletes on 14 sports teams.Since then, more than 100 former Ohio State University students have reported firsthand accounts of sexual misconduct by Strauss, the school said last month.Some of them, mostly former student athletes, have come forward to publicly claim that Strauss sexually abused them under the guise of a medical examination.According to the school, the alleged abuse took place between 1979 and 1997."We welcome the involvement and careful oversight of OCR and look forward to providing any information we can," said Gates Garrity-Rokous, the school's vice president and chief compliance officer, in a statement about the US Department of Education's investigation."We responded promptly and appropriately to the allegations received in April about Dr. Strauss," Garrity-Rokous continued. "We are confident in the independence and thoroughness of the investigation we launched then as well as our ongoing commitment to transparency."The-CNN-Wire 1910

The United Kingdom says it will be the first to conduct COVID-19 vaccine human challenge trials.It's different than other vaccine studies. People will be deliberately infected with the virus, which speeds up the research process.Pending approval, the process will start in January at a London hospital. It will require about 90 healthy young adults between the ages of 18 and 30.The group 1 Day Sooner has recruited from all over the world, including 3,000 Britons.“If the vaccine works, then ideally, people don't get infected and if people do, then they will be closely monitored and treated, but because these are young and healthy people taking part in the trial, I think, researchers feel comfortable doing so because the risks of death are on par with something like kidney donation for people who are young and healthy,” said Abie Rohrig with 1 Day Sooner.Before researchers test the vaccine, they'll do a characterization study. That's where volunteers are infected by getting a vaccine to determine the right amount of virus to give during the trial.Because of the risk, 1 Day Sooner is advocating for the entire process to be made public.Results could come in May. Even though that's likely after other COVID-19 vaccines are licensed, it's still important because we need billions of doses and because of the unique data human challenge trials provide.“Researchers can understand how the virus works in the human body. They can understand the biological markers of immunity. In fact, much of our understanding of other types of coronaviruses come from challenge studies that were conducted in the 1960s in Britain,” said Rohrig.Human challenge volunteers are paid and monitored for at least a year after. 1722

The U.S. will pay drug company Pfizer .95 billion to produce and deliver 100 million doses of the company's COVID-19 vaccine candidate should the drug prove effective in human trials the company said in a press release on Wednesday.Pfizer will deliver the vaccine if and when the drug receives Emergency Use Authorization from the FDA after a large-scale Phase 3 trial.According to the reports, the deal includes an option for the government to purchase an additional 500 million doses of the vaccine.“Expanding Operation Warp Speed’s diverse portfolio by adding a vaccine from Pfizer and BioNTech increases the odds that we will have a safe, effective vaccine as soon as the end of this year,” Health and Human Services Sec. Alex Azar said in a statement. “Depending on success in clinical trials, today’s agreement will enable the delivery of approximately 100 million doses of this vaccine to the American people.”Pfizer and German firm BioNTech are working together to develop the vaccine.On Monday, Pfizer said in a press release that results from Phases 1 and 2 of a German trial indicated that the drug "could potentially be administered safely, with a manageable tolerability profile," according to data from the tests.Biotech company Moderna is also working to develop a coronavirus vaccine. That candidate will move into Phase 3 testing by the end of the month, and the government has also agreed to purchase and distribute the drug should the large-scale test prove effective. 1497

来源：资阳报